Deutsch English Français

Contact

EP2844223

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2844223

EP2844223 - PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 16.12.2016 Database last updated on 22.08.2024
Most recent event Tooltip	30.07.2024	New entry: Reply to examination report
Applicant(s)	For all designated states ALCON INC. Rue Louis-d'Affry 6 1701 Fribourg / CH
	[2022/52]
Former [2019/23]	For all designated states Kala Pharmaceuticals, Inc. 490 Arsenal Way, Suite 120 Watertown, MA 02472 / US
Former [2017/38]	For all designated states Kala Pharmaceuticals, Inc. 100 Beaver Street, Suite 201 Waltham, MA 02453 / US
Former [2015/11]	For all designated states Kala Pharmaceuticals, Inc. 135 Beaver Street, Suite 309 Waltham, MA 02452 / US
Inventor(s)	01 / POPOV, Alexey 60 Hope Avenue Waltham, MA 02453 / US
	02 / ENLOW, Elizabeth, M. 85 Black Bear Drive Unit 1624 Waltham, MA 02451 / US
	03 / CHEN, Hongming 16 Birch Hill Road Belmont, MA 02478 / US
	04 / BOURASSA, James Apt. 15, 425 Broadway Somerville, MA 02145 / US
	[2020/30]
Former [2015/11]	01 / POPOV, Alexey 60 Hope Avenue Waltham, MA 02453 / US
	02 / ENLOW, Elizabeth, M. 85 Black Bear Drive Unit 1624 Waltham, MA 02451 / US
	03 / CHEN, Hongming 16 Birch Hill Road Belmont, MA 02478 / US
Representative(s)	Murgitroyd & Company 165-169 Scotland Street Glasgow G5 8PL / GB
	[N/P]
Former [2015/11]	Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR
Application number, filing date	13723629.5	03.05.2013
	WO2013US39540
Priority number, date	US201261642261P	03.05.2012 Original published format: US 201261642261 P
	US201261642313P	03.05.2012 Original published format: US 201261642313 P
	US201261738949P	18.12.2012 Original published format: US 201261738949 P
	US201361784701P	14.03.2013 Original published format: US 201361784701 P
	[2015/11]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2013166436
	Date:	07.11.2013
	Language:	EN
	[2013/45]
	Type:	A1 Application with search report
	No.:	EP2844223
	Date:	11.03.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 07.11.2013 takes the place of the publication of the European patent application.
	[2015/11]
Search report(s)	International search report - published on:	EP	07.11.2013
Classification	IPC:	A61K9/00, A61K47/26, A61K47/34, A61K9/10, A61K31/56	[2015/11]
	CPC:	A61K9/0048 (EP,US); A61K9/51 (KR); A61K31/195 (EP,US); A61K31/196 (EP,US); A61K31/407 (EP,US); A61K31/416 (EP,US); (+) A61K31/4365 (EP,US); A61K31/44 (EP,US); A61K31/4439 (EP,US); A61K31/506 (EP,US); A61K31/517 (EP,US); A61K31/56 (EP,KR,US); A61K47/26 (EP,US); A61K47/34 (EP,KR,US); A61K9/0051 (EP,US); A61K9/10 (EP,US); A61K9/16 (KR); A61K9/5015 (US); A61K9/5026 (US); A61K9/5031 (US); A61K9/5047 (US); A61P27/02 (EP); A61P27/06 (EP); A61P27/14 (EP); A61P43/00 (EP); A61P5/44 (EP); Y10S977/773 (KR) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/11]
Extension states	BA	23.10.2014
	ME	23.10.2014
Title	German:	PHARMAZEUTISCHE NANOPARTIKEL MIT VERBESSERTEM MUKOSALEM TRANSPORT	[2015/11]
	English:	PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT	[2015/11]
	French:	NANOPARTICULES PHARMACEUTIQUES À TRANSPORT MUCOSAL AMÉLIORÉ	[2015/11]
Entry into regional phase	23.10.2014	National basic fee paid
	23.10.2014	Designation fee(s) paid
	23.10.2014	Examination fee paid
Examination procedure	23.10.2014	Examination requested [2015/11]
	31.07.2015	Amendment by applicant (claims and/or description)
	15.12.2016	Despatch of a communication from the examining division (Time limit: M06)
	15.06.2017	Reply to a communication from the examining division
	19.09.2018	Despatch of a communication from the examining division (Time limit: M06)
	27.03.2019	Reply to a communication from the examining division
	20.08.2020	Despatch of a communication from the examining division (Time limit: M06)
	18.02.2021	Reply to a communication from the examining division
	20.08.2021	Despatch of a communication from the examining division (Time limit: M06)
	21.02.2022	Reply to a communication from the examining division
	28.03.2024	Despatch of a communication from the examining division (Time limit: M04)
	29.07.2024	Reply to a communication from the examining division
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.12.2016
Fees paid	Renewal fee
	13.05.2015	Renewal fee patent year 03
	10.06.2016	Renewal fee patent year 04
	10.05.2017	Renewal fee patent year 05
	25.05.2018	Renewal fee patent year 06
	23.05.2019	Renewal fee patent year 07
	22.05.2020	Renewal fee patent year 08
	18.05.2021	Renewal fee patent year 09
	25.03.2022	Renewal fee patent year 10
	14.03.2023	Renewal fee patent year 11
	13.03.2024	Renewal fee patent year 12
	Penalty fee
	Additional fee for renewal fee
	31.05.2016	04 M06 Fee paid on 10.06.2016
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]US2005191359 (GOLDSHTEIN RINA [IL], et al);
		[X]WO2006094808 (PHARMASOL GMBH [DE], et al);
		[Y]US2007149480 (GHOSH MALAY [US], et al);
		[X]US2007178051 (PRUITT JOHN [US], et al);
		[Y]US2008194468 (BODOR NICHOLAS S [US]);
		[Y]US2010076045 (CASTILLO ERNESTO J [US], et al);
		[Y]US2010222308 (ZHANG JING [CN]);
		[Y]WO2011106702 (UNIV JOHNS HOPKINS [US], et al);
		[Y]WO2012054923 (BIND BIOSCIENCES INC [US], et al);
		[YDP]WO2012061703 (UNIV JOHNS HOPKINS [US], et al);
	by applicant	WO2012061703

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p